Clinical Trial

LONG NAGOMI™ PMCF STUDY

Study acronym: LONG NAGOMI
Recruiting
View on ClinicalTrials.gov →
Summary
The study is designed as a prospective, multi-center, observational PMCF (post-market clinical follow-up) study of the Ultimaster Nagomi™ \_stent (lengths of 38, 44 and 50 mm) in the treatment of coronary artery disease according to the indications approved in the CE marking.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2026-02-02; most recent amendment 2026-06-19.
Status change: Not Yet Recruiting → Recruiting 2026-03-12
Trial Details
NCT Number NCT07399002
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease, Ischemic Heart Disease
Enrollment 1,039 participants
Start Date 2026-02-27
Primary Completion 2028-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-23